Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G F Gjerset

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Annals of Internal Medicine|January 15, 1991
Safety of factor VIIIG F Gjerset, J W Mosley
The Journal of Infectious Diseases|March 1, 1988
Phenotypes for group-specific component among patients exposed to human immunodeficiency virus by transfusionsG F Gjerset, G N Vyas, R Bhat, et al.
Clinical Immunology and Immunopathology|September 1, 1986
Abnormal B-cell function in hemophiliacs treated with cryoprecipitate and factor VIII and IX concentratesA Gorski, G F Gjerset, P J Martin, et al.
Blood|September 15, 1991
Treatment type and amount influenced human immunodeficiency virus seroprevalence of patients with congenital bleeding disordersG F Gjerset, M J Clements, R B Counts, et al.
Blood|September 1, 1984
Immunologic status of hemophilia patients treated with cryoprecipitate or lyophilized concentrateG F Gjerset, P J Martin, R B Counts, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Lymphocyte immunophenotypes among anti-HTLV-I/II-positive blood donors and recipients. The Transfusion Safety Study GroupM A Fletcher, G F Gjerset, J Hassett, et al.
The New England Journal of Medicine|December 14, 1989
Plasma viremia in human immunodeficiency virus infectionR W Coombs, A C Collier, J P Allain, et al.
Transfusion|June 1, 1993
Rapid freezing of whole blood or buffy coat samples for polymerase chain reaction and cell culture analysis: application to detection of human immunodeficiency virus in blood donor and recipient repositories. The Transfusion Safety Study GroupM Adams, T H Lee, M P Busch, et al.
Blood|September 1, 1985
Lymphadenopathy-associated virus antibodies and T cells in hemophiliacs treated with cryoprecipitate or concentrateG F Gjerset, G McGrady, R B Counts, et al.
Blood|August 1, 1992
Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study GroupM A Fletcher, J W Mosley, J Hassett, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Annals of Internal Medicine|January 15, 1991
Safety of factor VIIIG F Gjerset, J W Mosley
The Journal of Infectious Diseases|March 1, 1988
Phenotypes for group-specific component among patients exposed to human immunodeficiency virus by transfusionsG F Gjerset, G N Vyas, R Bhat, et al.
Clinical Immunology and Immunopathology|September 1, 1986
Abnormal B-cell function in hemophiliacs treated with cryoprecipitate and factor VIII and IX concentratesA Gorski, G F Gjerset, P J Martin, et al.
Blood|September 15, 1991
Treatment type and amount influenced human immunodeficiency virus seroprevalence of patients with congenital bleeding disordersG F Gjerset, M J Clements, R B Counts, et al.
Blood|September 1, 1984
Immunologic status of hemophilia patients treated with cryoprecipitate or lyophilized concentrateG F Gjerset, P J Martin, R B Counts, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Lymphocyte immunophenotypes among anti-HTLV-I/II-positive blood donors and recipients. The Transfusion Safety Study GroupM A Fletcher, G F Gjerset, J Hassett, et al.
The New England Journal of Medicine|December 14, 1989
Plasma viremia in human immunodeficiency virus infectionR W Coombs, A C Collier, J P Allain, et al.
Transfusion|June 1, 1993
Rapid freezing of whole blood or buffy coat samples for polymerase chain reaction and cell culture analysis: application to detection of human immunodeficiency virus in blood donor and recipient repositories. The Transfusion Safety Study GroupM Adams, T H Lee, M P Busch, et al.
Blood|September 1, 1985
Lymphadenopathy-associated virus antibodies and T cells in hemophiliacs treated with cryoprecipitate or concentrateG F Gjerset, G McGrady, R B Counts, et al.
Blood|August 1, 1992
Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study GroupM A Fletcher, J W Mosley, J Hassett, et al.
Pageof 2